US4633866A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Ophthalmic laser surgical method
Assignee: Individual
•
Filing: 1982-04-22
•
Granted: 1987-01-06
•
Expires: 2002-04-22
Abstract
Abstract An ophthalmic laser surgical method for treating or removing intraocular tissue anterior to the fundus while reducing the likelihood of photocoagulation damage to the fundus. Laser radiation in the infrared wavelength range is directed at the tissue to be treated or removed, the wavelength range being selected so as to minimize transmission of the laser radiation to the fundus by the ocular structures anterior to the retina.
Inventors
- 👤 Gholam Peyman
- 👤 Esa Viherkoski
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 04:25
CPC Classifications
A; A61; A61F; A61F9/00; A61F9/007; A61F9/008; A61F9/00821; A61F9/00825; A61F2009/00861; A61F2009/00874; A61F2009/00885; A61F2009/00887; A61F2009/00889
Claims Analysis
Total Claims: 21
Claim 1
Independent Claim
87 words
A method of laser surgical treatment of the eye comprising the steps of aiming a source capable of producing laser radiation, a major portion of which has a wavelength of from about 1100 nanometers to about 1350 nanometers or from about 1850 nanometers to about 2050 nanometers, at the intraocular tissue to be treated and thereafter exposing said tissue to said laser radiation for a time sufficient and at an intensity sufficient to induct photocoagulation or membrane disruption of said tissue whereby the surgical method is effected.
Claim 2
Independent Claim
87 words
A method of laser surgical treatment of the eye comprising the steps of aiming a source capable of producing laser radiation, a major portion of which has a wavelength of from about 1100 nanometers to about 1350 nanometers or from about 1850 nanometers to about 2050 nanometers, at the intraocular tissue to be treated and thereafter exposing said tissue to said laser radiation for a time sufficient and at an intensity sufficient to induct photocoagulation or membrane disruption of said tissue whereby the surgical method is effected.
Claim 3
Independent Claim
71 words
A method of laser surgical treatment or disruption of intraocular tissue anterior to the fundus of the eye, comprising the steps of exposing said tissue to laser radiation having a wavelength such that an amount greater than about 80% of said laser radiation is absorbed by the vitreous before reaching the fundus and inducing photocoagulation or membrane disruption of said tissue with said laser radiation whereby the surgical method is effected.
Claim 4
Independent Claim
71 words
A method of laser surgical treatment or disruption of intraocular tissue anterior to the fundus of the eye, comprising the steps of exposing said tissue to laser radiation having a wavelength such that an amount greater than about 80% of said laser radiation is absorbed by the vitreous before reaching the fundus and inducing photocoagulation or membrane disruption of said tissue with said laser radiation whereby the surgical method is effected.
Claim 5
Dependent Claim
22 words
A method according to claim 2 wherein said laser radiation has a wavelength of from about 1100 nanometers to about 1350 nanmeters.
Claim 6
Dependent Claim
22 words
A method according to claim 2 wherein said laser radiation has a wavelength of from about 1850 nanometers to about 2050 nanometers.
Claim 7
Dependent Claim
25 words
A method according to claim 3 or claim 4 wherein said laser radiation is produced by a laser apparatus employing a neodynium-doped yttrium-aluminum garnet crystal.
Claim 8
Dependent Claim
12 words
A method according to claim 5 wherein said laser apparatus is mode-locked.
Claim 9
Dependent Claim
20 words
A method according to claim 2 wherein said laser radiation is directed into the eye in a series of pulses.
Claim 10
Dependent Claim
25 words
A method according to claim 7 wherein each of said pulses of laser radiation has a strength of from about 100 milli-Joules to about milli-Joules.
Claim 11
Dependent Claim
25 words
A method according to claim 7 wherein each of said pulses of laser radiation has a duration of from about 10 to about 50 nanoseconds.
Claim 12
Independent Claim
120 words
A method of laser surgical treatment or disruption of intraocular tissue anterior to the fundus of the eye while reducing damage to the fundus caused by undesired penetration of laser radiation beyond the tissue to be treated, comprising the steps of exposing said tissue to a series of pulses of laser radiation having a wavelength of from about 1100 nanometers to about 1350 nanometers, said radiation being produced by an apparatus employing a neodymium-doped yttrium-aluminum garnet crystal, and said pulses havin a strength of from about 100 milli-Joules to about 150 milli-Joules and having a duration of from about 10 to about 50 nanoseconds and inducing photocoagulation or membrane disruption with said laser radiation whereby the surgical method is effected.
Claim 13
Independent Claim
120 words
A method of laser surgical treatment or disruption of intraocular tissue anterior to the fundus of the eye while reducing damage to the fundus caused by undesired penetration of laser radiation beyond the tissue to be treated, comprising the steps of exposing said tissue to a series of pulses of laser radiation having a wavelength of from about 1100 nanometers to about 1350 nanometers, said radiation being produced by an apparatus employing a neodymium-doped yttrium-aluminum garnet crystal, and said pulses havin a strength of from about 100 milli-Joules to about 150 milli-Joules and having a duration of from about 10 to about 50 nanoseconds and inducing photocoagulation or membrane disruption with said laser radiation whereby the surgical method is effected.
Claim 14
Dependent Claim
24 words
A method according to claim 10 wherein said laser radiation has a wavelength in the range of from about 1300 nanometers to about nanometers.
Claim 15
Dependent Claim
12 words
A method according to claim 10 wherein said laser apparatus is mode-locked.
Claim 16
Dependent Claim
76 words
An ophthalmic laser surgical method for treating or disrupting intraocular tissue anterior to the fundus of the eye while reducing the likelihood of photocoagulation damage to the funuds, comprising the steps of directing at said intraocular tissue laser radiation having a wavelength of from about 1100 nanometers to about 1350 nanometers of from about 1850 nanometers to about 2050 nanometers and inducing photocoagulation or membrane disruption with said laser radiation whereby the surgical method is effected.
Claim 17
Dependent Claim
76 words
An ophthalmic laser surgical method for treating or disrupting intraocular tissue anterior to the fundus of the eye while reducing the likelihood of photocoagulation damage to the funuds, comprising the steps of directing at said intraocular tissue laser radiation having a wavelength of from about 1100 nanometers to about 1350 nanometers of from about 1850 nanometers to about 2050 nanometers and inducing photocoagulation or membrane disruption with said laser radiation whereby the surgical method is effected.
Claim 18
Independent Claim
45 words
A method of disrupting an intraocular membrane comprising directing at said membrane laser radiation having a wavelength of from about 1100 nanometers to about 1350 nanometers and inducing intraocular membrane disruption with said laser radiation whereby said method of disrupting said intraocular membrane is effected.
Claim 19
Independent Claim
45 words
A method of disrupting an intraocular membrane comprising directing at said membrane laser radiation having a wavelength of from about 1100 nanometers to about 1350 nanometers and inducing intraocular membrane disruption with said laser radiation whereby said method of disrupting said intraocular membrane is effected.
Claim 20
Dependent Claim
30 words
A method according to claim 14 for disrupting a pupillary membrane comprising directing at said membrane laser radiation having a wavelength of from about 1100 nanometers to about 1200 nanometers.
Claim 21
Dependent Claim
32 words
A method according to claim 14 for disrupting a vitreous membrane comprising directing at said membrane laser radiation having a wavelength in the range of about 1300 nanometers to about 1310 nanometers.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1990-01-05 | 1990-07-07 | 1991-01-06 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1994-01-05 | 1994-07-07 | 1995-01-06 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1998-01-05 | 1998-07-07 | 1999-01-06 | $7700.00 | Window Closed / Lapsed |